BlackRock Amends Anterix Stake, Maintains Significant Position
Ticker: ATEX · Form: SC 13G/A · Filed: Jan 29, 2024 · CIK: 1304492
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investing
TL;DR
**BlackRock still owns a big chunk of Anterix, signaling institutional confidence.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on January 29, 2024, disclosing its ownership of Anterix Inc. common stock as of December 31, 2023. This filing indicates that BlackRock, a major institutional investor, continues to hold a significant stake in Anterix, signaling ongoing confidence in the company. For investors, this means a large, influential fund manager sees value in Anterix, which can be a positive indicator for the stock's stability and future prospects.
Why It Matters
This filing shows that BlackRock, a major institutional investor, still holds a substantial amount of Anterix stock, which can be seen as a vote of confidence in the company's future.
Risk Assessment
Risk Level: low — The filing indicates a stable institutional ownership by BlackRock, which generally reduces volatility and provides a level of support for the stock.
Analyst Insight
An investor should note BlackRock's continued institutional ownership as a potential sign of stability, but also research Anterix's fundamentals and recent performance to make an informed decision, as this filing doesn't disclose changes in ownership percentage.
Key Players & Entities
- BlackRock Inc. (company) — the institutional investor filing the SC 13G/A
- Anterix Inc. (company) — the subject company whose securities are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 29, 2024 (date) — the filing date of the SC 13G/A
Forward-Looking Statements
- BlackRock will maintain a significant stake in Anterix Inc. throughout 2024. (BlackRock Inc.) — medium confidence, target: December 31, 2024
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing under the Securities Exchange Act of 1934.
Who is the filer of this SC 13G/A?
The filer of this SC 13G/A is BlackRock Inc., a major institutional investment manager.
What company's securities are the subject of this filing?
The subject company whose securities are being reported is Anterix Inc., identified by CUSIP Number 03676C100.
What was the date of the event that required this filing?
The date of the event which required the filing of this statement was December 31, 2023.
Under which rule was this Schedule 13G filed?
This Schedule 13G was filed under Rule 13d-1(b), as indicated by the checked box in the filing.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 29, 2024 regarding Anterix Inc. (ATEX).